Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $132,443 | 34 | 86.1% |
| Travel and Lodging | $15,561 | 22 | 10.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,730 | 1 | 3.1% |
| Food and Beverage | $1,101 | 15 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $62,192 | 38 | $0 (2018) |
| Janssen Research & Development, LLC | $47,999 | 10 | $0 (2024) |
| PFIZER INC. | $12,125 | 6 | $0 (2019) |
| Mallinckrodt LLC | $7,556 | 3 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $7,000 | 6 | $0 (2023) |
| Organon LLC | $4,890 | 1 | $0 (2023) |
| American Regent | $4,878 | 4 | $0 (2019) |
| Shionogi Inc | $4,158 | 2 | $0 (2024) |
| Janssen Global Services, LLC | $1,620 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,417 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,158 | 3 | Shionogi Inc ($4,158) |
| 2023 | $11,890 | 7 | Regeneron Pharmaceuticals, Inc. ($7,000) |
| 2022 | $16,500 | 3 | Janssen Research & Development, LLC ($16,500) |
| 2021 | $30,369 | 6 | Janssen Research & Development, LLC ($28,749) |
| 2020 | $3,167 | 2 | Janssen Research & Development, LLC ($1,750) |
| 2019 | $6,878 | 5 | American Regent ($4,878) |
| 2018 | $43,604 | 20 | Shire North American Group Inc ($26,149) |
| 2017 | $36,269 | 26 | Shire North American Group Inc ($36,043) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 08/01/2024 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $4,130.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 08/01/2024 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $28.14 | General |
| Category: Infections and Infectious Diseases | ||||||
| 07/21/2023 | Organon LLC | — | Consulting Fee | Cash or cash equivalent | $4,890.00 | General |
| 03/20/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/20/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/20/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/20/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/20/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/20/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 04/27/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $9,125.00 | General |
| 02/18/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| 10/05/2021 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $1,620.00 | General |
| 09/13/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $6,333.00 | General |
| 06/24/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,958.00 | General |
| 06/07/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 04/09/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $14,458.00 | General |
| 03/24/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 12/28/2020 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 01/11/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,417.00 | General |
| 12/03/2019 | American Regent | INJECTAFER (Drug) | Consulting Fee | Cash or cash equivalent | $3,167.26 | General |
| Category: Anemia | ||||||
| 10/18/2019 | American Regent | INJECTAFER (Drug) | Consulting Fee | Cash or cash equivalent | $476.60 | General |
| Category: Anemia | ||||||
| 10/07/2019 | PFIZER INC. | ELIQUIS (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/10/2019 | American Regent | INJECTAFER (Drug) | Consulting Fee | Cash or cash equivalent | $617.30 | General |
| Category: Anemia | ||||||
About Robert Ward
Robert Ward is a Neonatal-Perinatal Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144309717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Ward has received a total of $153,835 in payments from pharmaceutical and medical device companies, with $5,158 received in 2024. These payments were reported across 72 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($132,443).
Practice Information
- Specialty Neonatal-Perinatal Medicine
- Location Salt Lake City, UT
- Active Since 11/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080N0001X
- Entity Type Individual
- NPI Number 1144309717
Products in Payments
- ELIQUIS (Drug) $11,899
- EYLEA HD (Biological) $7,000
- OBIZUR (Biological) $5,627
- INJECTAFER (Drug) $4,878
- Fetroja (Drug) $4,158
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neonatal-Perinatal Medicine Doctors in Salt Lake City
Bradley Yoder
Neonatal-Perinatal Medicine — Payments: $15,148
Robert Christensen, Md, MD
Neonatal-Perinatal Medicine — Payments: $13,289
Dr. Mariana Baserga, M.d, M.D
Neonatal-Perinatal Medicine — Payments: $881.97
Dr. Anupam Verma, Md, MD
Neonatal-Perinatal Medicine — Payments: $755.55
Dr. Ellen Liu, Md, MD
Neonatal-Perinatal Medicine — Payments: $267.51
Dr. Con Ling, Md, MD
Neonatal-Perinatal Medicine — Payments: $160.84